FR2919182B1 - Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants - Google Patents

Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants

Info

Publication number
FR2919182B1
FR2919182B1 FR0705428A FR0705428A FR2919182B1 FR 2919182 B1 FR2919182 B1 FR 2919182B1 FR 0705428 A FR0705428 A FR 0705428A FR 0705428 A FR0705428 A FR 0705428A FR 2919182 B1 FR2919182 B1 FR 2919182B1
Authority
FR
France
Prior art keywords
cholestane
seco
antioxidants
oxime derivative
oxime
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0705428A
Other languages
English (en)
Other versions
FR2919182A1 (fr
Inventor
Rebecca Pruss
Cyrille Drouot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trophos SA
Original Assignee
Trophos SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0705428A priority Critical patent/FR2919182B1/fr
Application filed by Trophos SA filed Critical Trophos SA
Priority to MX2010000913A priority patent/MX2010000913A/es
Priority to BRPI0814667-5A2A priority patent/BRPI0814667A2/pt
Priority to JP2010517451A priority patent/JP2010534228A/ja
Priority to AU2008306755A priority patent/AU2008306755B2/en
Priority to EP08835696A priority patent/EP2173316A2/fr
Priority to US12/670,482 priority patent/US8338488B2/en
Priority to PCT/FR2008/001102 priority patent/WO2009044011A2/fr
Priority to CA2694148A priority patent/CA2694148A1/fr
Priority to RU2010106609/15A priority patent/RU2476225C2/ru
Priority to NZ582647A priority patent/NZ582647A/xx
Publication of FR2919182A1 publication Critical patent/FR2919182A1/fr
Application granted granted Critical
Publication of FR2919182B1 publication Critical patent/FR2919182B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR0705428A 2007-07-25 2007-07-25 Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants Expired - Fee Related FR2919182B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0705428A FR2919182B1 (fr) 2007-07-25 2007-07-25 Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants
CA2694148A CA2694148A1 (fr) 2007-07-25 2008-07-24 Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants
JP2010517451A JP2010534228A (ja) 2007-07-25 2008-07-24 ３，５−セコ−４−ノル−コレスタンの少なくとも１種のオキシム誘導体の抗酸化剤としての使用
AU2008306755A AU2008306755B2 (en) 2007-07-25 2008-07-24 Use of at least one oxime derivative of 3,5-seco-4-norcholestane as antioxidants
EP08835696A EP2173316A2 (fr) 2007-07-25 2008-07-24 Utilisation d'au moins un dérivé oxime du 3,5-seco-4-nor-cholestane comme antioxydants
US12/670,482 US8338488B2 (en) 2007-07-25 2008-07-24 Use of at least one oxime derivative of 3,5-seco-4-nor-cholestane as antioxidants
MX2010000913A MX2010000913A (es) 2007-07-25 2008-07-24 Uso de cuando menos un derivado de oxima de 3,5-seco-4-nor-colesta do como antioxidante.
BRPI0814667-5A2A BRPI0814667A2 (pt) 2007-07-25 2008-07-24 Utilização de pelo menos um derivado oxima do 3,5-seco-4-nor-colestano ou um dos seus sais de adição com os ácidos aceitáveis, ou de um dos seus ésteres ou um dos sais de adição dos referidos ésteres com os ácidos aceitáveis.
RU2010106609/15A RU2476225C2 (ru) 2007-07-25 2008-07-24 Применение по меньшей мере одного оксимного производного 3,5-секо-4-норхолестана в качестве антиоксидантов
NZ582647A NZ582647A (en) 2007-07-25 2008-07-24 Use of at least one oxime derivative of 3,5-seco-4-norcholestane as antioxidants
PCT/FR2008/001102 WO2009044011A2 (fr) 2007-07-25 2008-07-24 Utilisation d'au moins un dérivé oxime du 3,5-seco-4-nor-cholestane comme antioxydants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0705428A FR2919182B1 (fr) 2007-07-25 2007-07-25 Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants

Publications (2)

Publication Number Publication Date
FR2919182A1 FR2919182A1 (fr) 2009-01-30
FR2919182B1 true FR2919182B1 (fr) 2009-11-13

Family

ID=39167368

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0705428A Expired - Fee Related FR2919182B1 (fr) 2007-07-25 2007-07-25 Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants

Country Status (11)

Country Link
US (1) US8338488B2 (fr)
EP (1) EP2173316A2 (fr)
JP (1) JP2010534228A (fr)
AU (1) AU2008306755B2 (fr)
BR (1) BRPI0814667A2 (fr)
CA (1) CA2694148A1 (fr)
FR (1) FR2919182B1 (fr)
MX (1) MX2010000913A (fr)
NZ (1) NZ582647A (fr)
RU (1) RU2476225C2 (fr)
WO (1) WO2009044011A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2874923B1 (fr) * 2004-09-07 2006-10-27 Trophos Sa Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation
FR2919180B1 (fr) * 2007-07-25 2009-11-27 Trophos Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants
FR2940650B1 (fr) * 2008-12-29 2017-01-27 Trophos Nouveaux derives d'oxime du 3,5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant,et procede de preparation
FR2979239A1 (fr) * 2011-08-25 2013-03-01 Trophos Liposome comprenant au moins un derive de cholesterol

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB546127A (en) * 1940-01-26 1942-06-29 Nat Aniline & Chem Co Inc Improvements in or relating to air-hardenable coating compositions
FR2581542B1 (fr) 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
IT1230096B (it) * 1989-04-27 1991-10-05 Donegani Guido Ist Processo per l'ossidazione di ammine sature primarie ad ossime.
RU2004234C1 (ru) * 1993-04-06 1993-12-15 Фармацевтическое научно-производственное объединение "Ретиноиды" Композици , стимулирующа регенерацию эпители
FR2710843B1 (fr) * 1993-10-04 1995-12-01 Oreal Composition d'organopolysiloxane d'aspect gélifié, sans gélifiant, utilisable en cosmétique et dermatologie.
JPH1077472A (ja) * 1996-08-30 1998-03-24 Toyo Suisan Kaisha Ltd 天然型酸化防止剤およびその製造方法
DE19960105A1 (de) * 1999-12-14 2001-06-21 Haarmann & Reimer Gmbh Catecholoxime und ihre Verwendung in kosmetischen und dermatologischen Zubereitungen
WO2001078533A2 (fr) * 2000-04-18 2001-10-25 Société des Produits Nestlé S.A. Modules nutritionnels
RU2178975C1 (ru) * 2000-06-08 2002-02-10 Борц Михаил Самуилович Пищевой продукт с биологически активными добавками
ITMI20011022A1 (it) * 2001-05-17 2002-11-17 Indena Spa Composizioni farmaceutiche e cosmetiche contro l'invecchiamento cutaneo
JP4447255B2 (ja) * 2003-06-26 2010-04-07 旭化成ケミカルズ株式会社 環状脂肪族オキシムの製法
FR2874923B1 (fr) 2004-09-07 2006-10-27 Trophos Sa Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation
US7582126B2 (en) * 2005-12-20 2009-09-01 Arkema France Fatty ester compositions with improved oxidative stability
FR2898272B1 (fr) * 2006-03-09 2008-07-04 Trophos Sa Utilisation de derives du 3,5-seco-4-nor-cholestrane pour l'obtention d'un medicament cytoprotecteur
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
FR2919180B1 (fr) * 2007-07-25 2009-11-27 Trophos Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants

Also Published As

Publication number Publication date
WO2009044011A3 (fr) 2009-11-05
CA2694148A1 (fr) 2009-04-09
BRPI0814667A2 (pt) 2014-09-30
AU2008306755B2 (en) 2013-04-18
AU2008306755A1 (en) 2009-04-09
US20100267837A1 (en) 2010-10-21
RU2476225C2 (ru) 2013-02-27
JP2010534228A (ja) 2010-11-04
RU2010106609A (ru) 2011-08-27
FR2919182A1 (fr) 2009-01-30
EP2173316A2 (fr) 2010-04-14
WO2009044011A2 (fr) 2009-04-09
NZ582647A (en) 2013-03-28
MX2010000913A (es) 2010-03-01
US8338488B2 (en) 2012-12-25

Similar Documents

Publication Publication Date Title
BRPI0816970A2 (pt) 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
IL210951A0 (en) Cholest-4-en-3-one oxime derivatives, compositions comprising the same and uses thereof
ATE555107T1 (de) 2-aza-bicyclo-ä2,2,1-üheptan-derivate
BRPI0811718A2 (pt) Derivados de 3,3-espiroindolinona
HK1149007A1 (en) Amide compounds, compositions and uses thereof
IL208781A (en) Immunotherapy is based on dioxygenase –2,3 indoleamine
BRPI0815452A2 (pt) "equipamento para gastropexia"
DK2205562T3 (da) 1,1,1-trifluor-2-hydroxy-3-phenylpropanderivater
GB0712303D0 (en) New use for cannabinoid
IL208059A0 (en) Novel hsp90 inhibitory carbazole derivatives, compositions containing same and use thereof
ZA200810640B (en) 1,5 -Diphenylpyrazoles II as HSP90 Inhibitors
ZA200906271B (en) Novel composition based on cholest-4-ene-3-one oxime
SI2225238T1 (sl) Derivati amidov 6,7-dihidro-5H-imidazo(1,2-a)imidazol-3-karboksilne kisline
IL201921A0 (en) 1,3-dihydroimidazol-2-thione derivative as inhibitors of dopamine-beta-hydroxylase
ZA201008657B (en) 4,5-dihydro-oxazol-2-yl derivatives
EP2351732A4 (fr) Nouveau composé de ramaline et utilisation de celui-ci
BRPI0815059A2 (pt) Derivado de 1,3-di-hidroisoindol
IL213473A0 (en) Crystalline forms of genistein, compositions comprising the same and uses thereof
DK2203457T3 (da) Dispiro-1,2,4-trioxolaner som antimalariamidler
IL208262A0 (en) Hydroxyquinoxalinecar boxamide derivatives, compositions comprising the same and uses thereof
FR2919180B1 (fr) Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants
FR2919182B1 (fr) Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants
EP2202231A4 (fr) Dérivé de 2,3-dihydroiminoisoindole
IL217928A0 (en) Amide derivatives, compositions comprising the same and uses thereof
DK2241564T3 (da) 3,8-diaminotetrahydroquinolin-derivat

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100331

RN Application for restoration
D3 Ip right revived
ST Notification of lapse

Effective date: 20140331